Monday - December 23, 2024

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

2024-11-26

ALEXANDRIA, Virginia, Nov. 26 -- CUE BIOPHARMA, INC., Boston, Massachusetts has been assigned a patent (No. US 12152061 B2, initially filed Aug. 24, 2023) developed by Ronald D. Seidel, III, Boston, Massachusetts, and Rodolfo J. Chaparro, Cambridge, Massachusetts, for "T-cell modulatory multimeric polypeptides and methods of use thereof." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

Information Request Form

Copyright Targeted News Service 2024